Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2007 | Arsenic and diabetes and hypertension in human populations: A review | Chen C.-J.; Wang S.-L.; Chiou J.-M.; CHIN-HSIAO TSENG ; Chiou H.-Y.; Hsueh Y.-M.; Chen S.-Y.; Wu M.-M.; Lai M.-S. | Toxicology and Applied Pharmacology | 145 | 125 | |
2017 | Arsenic Exposure From Drinking Water and the Incidence of CKD in Low to Moderate Exposed Areas of Taiwan: A 14-Year Prospective Study | Hsu L.-I.; Hsieh F.-I.; Wang Y.-H.; TAI-SHUAN LAI ; Wu M.-M.; Chen C.-J.; Chiou H.-Y.; Hsu K.-H. | American Journal of Kidney Diseases | 39 | 35 | |
2010 | Arsenic in drinking water and risk of urinary tract cancer: A follow-up study from Northeastern Taiwan | CHI-LING CHEN ; Chiou H.-Y.; Hsu L.-I.; Hsueh Y.-M.; Wu M.-M.; Wang Y.-H.; Chen C.-J. | Cancer Epidemiology Biomarkers and Prevention | 127 | 97 | |
2010 | Arsenic-induced QT dispersion is associated with atherosclerotic diseases and predicts long-term cardiovascular mortality in subjects with previous exposure to arsenic: A 17-year follow-up study | Wang C.-H.; CHI-LING CHEN ; CHUHSING KATE HSIAO ; FU-TIEN CHIANG ; Hsu L.-I.; Chiou H.-Y.; Hsueh Y.-M.; Wu M.-M.; Chen C.-J. | Cardiovascular Toxicology | 28 | 21 | |
2013 | The association of diabetes mellitus with subsequent internal cancers in the arsenic-exposed area of Taiwan | Hsu L.-I.; Wang Y.-H.; Chiou H.-Y.; Wu M.-M.; Yang T.-Y.; Chen Y.-H.; CHIN-HSIAO TSENG ; Chen C.-J. | Journal of Asian Earth Sciences | 3 | 3 | |
2011 | Association of heme oxygenase-1 GT-repeat polymorphism with blood pressure phenotypes and its relevance to future cardiovascular mortality risk: An observation based on arsenic-exposed individuals | Wu M.-M.; Chiou H.-Y.; CHI-LING CHEN ; Hsu L.-I.; Lien L.-M.; Wang C.-H.; Hsieh Y.-C.; Wang Y.-H.; Hsueh Y.-M.; Lee T.-C.; WEN-FANG CHENG ; Chen C.-J. | Atherosclerosis | 23 | 19 | |
2002 | Biological gradient between long-term arsenic exposure and carotid atherosclerosis | Wang C.-H.; JIANN-SHING JENG ; Yip P.-K.; CHI-LING CHEN ; Hsu L.-I.; Hsueh Y.-M.; Chiou H.-Y.; Wu M.-M.; Chen C.-J. | Circulation | 230 | 197 | |
2005 | Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan | Chen C.-J.; Hsu L.-I.; Wang C.-H.; WEI-LIANG SHIH ; Hsu Y.-H.; Tseng M.-P.; Lin Y.-C.; Chou W.-L.; Chen C.-Y.; Lee C.-Y.; Wang L.-H.; Cheng Y.-C.; CHI-LING CHEN ; Chen S.-Y.; Wang Y.-H.; Hsueh Y.-M.; Chiou H.-Y.; Wu M.-M. | Toxicology and Applied Pharmacology | 181 | 155 | |
2013 | Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer | Wang Y.-H.; Yeh S.-D.; Wu M.-M.; Liu C.-T.; Shen C.-H.; Shen K.-H.; YEONG-SHIAU PU ; Hsu L.-I.; Chiou H.-Y.; Chen C.-J. | Journal of Hazardous Materials | 34 | 31 | |
2014 | Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure | Yang T.-Y.; Hsu L.-I.; Chiu A.W.; YEONG-SHIAU PU ; Wang S.-H.; Liao Y.-T.; Wu M.-M.; Wang Y.-H.; Chang C.-H.; Lee T.-C.; Chen C.-J. | Environmental Research | 29 | 25 | |
2016 | Effect of heme oxygenase-1 gene promoter polymorphism on cancer risk by histological subtype: A prospective study in arseniasis-endemic areas in Taiwan | Wu M.-M.; Lee C.-H.; Hsu L.-I.; WEN-FANG CHENG ; Lee T.-C.; Wang Y.-H.; Chiou H.-Y.; Chen C.-J. | International Journal of Cancer | 9 | 9 | |
2016 | Effects of Arsenic in Drinking Water on Risk of Hepatitis?or?Cirrhosis in Persons With and Without Chronic?Viral?Hepatitis | Hsu L.-I.; Wang Y.-H.; Hsieh F.-I.; Yang T.-Y.; Wen-Juei Jeng R.; Liu C.-T.; CHI-LING CHEN ; Hsu K.-H.; Chiou H.-Y.; Wu M.-M.; Chen C.-J. | Clinical Gastroenterology and Hepatology | 27 | 22 | |
2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 19 | 19 | |
2010 | GT-repeat polymorphism in the heme oxygenase-1 gene promoter and the risk of carotid atherosclerosis related to arsenic exposure | Wu M.-M.; Chiou H.-Y.; Lee T.-C.; CHI-LING CHEN ; Hsu L.-I.; Wang Y.-H.; Huang W.-L.; Hsieh Y.-C.; Yang T.-Y.; Lee C.-Y.; Yip P.-K.; Wang C.-H.; Hsueh Y.-M.; CHI-LING Chen C.-J. | Journal of Biomedical Science | 31 | 27 | |
2010 | GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan | Wu M.-M.; Chiou H.-Y.; CHI-LING CHEN ; Wang Y.-H.; Hsieh Y.-C.; Lien L.-M.; Lee T.-C.; Chen C.-J. | Toxicology and Applied Pharmacology | 35 | 29 | |
2009 | Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan | Wang C.-H.; CHI-LING CHEN ; CHUHSING KATE HSIAO ; FU-TIEN CHIANG ; Hsu L.-I.; Chiou H.-Y.; Hsueh Y.-M.; Wu M.-M.; Chen C.-J. | Toxicology and Applied Pharmacology | 34 | 22 | |
2004 | Ingested arsenic, cigarette smoking, and lung cancer risk: A follow-up study in arseniasis-endemic areas in Taiwan | CHI-LING CHEN ; Hsu L.-I.; Chiou H.-Y.; Hsueh Y.-M.; Chen S.-Y.; Wu M.-M.; Chen C.-J. | Journal of the American Medical Association | 235 | 204 | |
2013 | Lifetime risk of urothelial carcinoma and lung cancer in the arseniasis-endemic area of Northeastern Taiwan | Yang T.-Y.; Hsu L.-I.; Chen H.-C.; Chiou H.-Y.; Hsueh Y.-M.; Wu M.-M.; CHI-LING CHEN ; Wang Y.-H.; Liao Y.-T.; Chen C.-J. | Journal of Asian Earth Sciences | 16 | 12 | |
2014 | Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation | Wang H.-H.; Wu M.-M.; Chan M.W.Y.; YEONG-SHIAU PU ; Chen C.-J.; Lee T.-C. | Archives of Toxicology | 21 | 19 | |
2017 | Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma | Wu M.-M.; Li C.-F.; Lin L.-F.; Wang A.S.; YEONG-SHIAU PU ; Wang H.-H.; Mar A.-C.; Chen C.-J.; Lee T.-C. | Oncotarget | 12 | 11 |